Back to GetFilings.com



Table of Contents

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 10-Q

 


 

QUARTERLY REPORT UNDER SECTION 13 or 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

For Quarter Ended November 27, 2004

 

Commission File Number 0-6365

 


 

APOGEE ENTERPRISES, INC.

(Exact name of registrant as specified in its charter)

 


 

Minnesota   41-0919654

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

7900 Xerxes Ave S. – Suite 1800, Minneapolis, MN   55431
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (952) 835-1874

 

Common Stock $0.33 1/3 Par Value

(Title of each class)

 


 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).    Yes  x    No  ¨

 

As of December 31, 2004, 27,359,399 shares of the Registrant’s common stock, par value $0.33 1/3 per share, were outstanding.

 



Table of Contents

APOGEE ENTERPRISES, INC. AND SUBSIDIARIES

 

          Page

PART I

   Financial Information     

Item 1.

   Financial Statements (Unaudited):     
     Consolidated Balance Sheets as of November 27, 2004 and February 28, 2004    3
     Consolidated Results of Operations for the Three and Nine Months Ended November 27, 2004 and November 29, 2003    4
     Consolidated Statements of Cash Flows for the Nine Months Ended November 27, 2004 and November 29, 2003    5
     Notes to Consolidated Financial Statements    6

Item 2.

   Management’s Discussion and Analysis of Financial Condition and Results of Operations    12

Item 3.

   Quantitative and Qualitative Disclosures About Market Risk    19

Item 4.

   Controls and Procedures    19

PART II

   Other Information     

Item 1.

   Legal Proceedings    20

Item 2.

   Unregistered Sales and Use of Proceeds    20

Item 6.

   Exhibits    20

Signature

    

 

2


Table of Contents

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

CONSOLIDATED BALANCE SHEETS

(unaudited)

 

(In thousands, except per share data)


  

November 27,

2004


    February 28,
2004


 

Assets

                

Current assets

                

Cash and cash equivalents

   $ 9,570     $ 7,822  

Receivables, net of allowance for doubtful accounts

     125,213       99,968  

Inventories

     36,259       35,533  

Refundable income taxes

     —         2,578  

Current assets of discontinued operations

     —         1,343  

Deferred tax assets

     6,224       6,700  

Other current assets

     3,527       3,910  
    


 


Total current assets

     180,793       157,854  
    


 


Property, plant and equipment, net

     100,131       98,536  

Marketable securities available for sale

     12,748       13,987  

Investments in affiliated companies

     16,132       16,668  

Assets of discontinued operations

     1,182       3,260  

Goodwill

     42,960       42,960  

Intangible assets, at cost less accumulated amortization of $1,253 and $845, respectively

     1,529       1,365  

Other assets

     1,240       573  
    


 


Total assets

   $ 356,715     $ 335,203  
    


 


Liabilities and Shareholders’ Equity

                

Current liabilities

                

Accounts payable

   $ 42,092     $ 38,293  

Accrued expenses

     43,213       41,294  

Current liabilities of discontinued operations

     2,584       3,643  

Billings in excess of costs and earnings on uncompleted contracts

     13,798       7,100  

Accrued income taxes

     10,959       —    

Current installments of long-term debt

     300       308  
    


 


Total current liabilities

     112,946       90,638  
    


 


Long-term debt, less current installments

     35,000       39,650  

Long-term self-insurance reserves

     13,064       14,065  

Other long-term liabilities

     11,326       14,104  

Liabilities of discontinued operations

     8,816       9,290  

Commitments and contingent liabilities (Note 11)

                

Shareholders’ equity

                

Common stock of $0.33-1/3 par value; authorized 50,000,000 shares; issued and outstanding 27,354,000 and 27,358,000, respectively

     9,118       9,119  

Additional paid-in capital

     57,058       55,749  

Retained earnings

     112,119       106,271  

Common stock held in trust

     (5,654 )     (5,368 )

Deferred compensation obligations

     5,654       5,368  

Unearned compensation

     (2,064 )     (2,474 )

Accumulated other comprehensive loss

     (668 )     (1,209 )
    


 


Total shareholders’ equity

     175,563       167,456  
    


 


Total liabilities and shareholders’ equity

   $ 356,715     $ 335,203  
    


 


 

See accompanying notes to consolidated financial statements.

 

3


Table of Contents

CONSOLIDATED RESULTS OF OPERATIONS

(unaudited)

 

     Three months ended

    Nine months ended

 

(In thousands, except per share data)


   Nov. 27,
2004


    Nov. 29,
2003


    Nov. 27,
2004


    Nov. 29,
2003


 

Net sales

   $ 157,146     $ 143,562     $ 454,004     $ 400,873  

Cost of sales

     127,034       115,232       369,934       325,693  
    


 


 


 


Gross profit

     30,112       28,330       84,070       75,180  

Selling, general and administrative expenses

     21,648       21,929       64,378       63,647  
    


 


 


 


Operating income

     8,464       6,401       19,692       11,533  

Interest income

     348       131       1,886       443  

Interest expense

     872       897       2,647       2,779  

Other income (expense), net

     232       (4 )     195       (11 )

Equity in loss of affiliated companies

     (82 )     (816 )     (548 )     (822 )
    


 


 


 


Earnings from continuing operations before income taxes

     8,090       4,815       18,578       8,364  

Income tax expense (benefit)

     2,533       (639 )     5,611       —    
    


 


 


 


Earnings from continuing operations

     5,557       5,454       12,967       8,364  

(Loss) earnings from discontinued operations, net of income taxes

     —         (3,004 )     67       (7,458 )
    


 


 


 


Net earnings

   $ 5,557     $ 2,450     $ 13,034     $ 906  
    


 


 


 


Earnings (loss) per share – basic

                                

Earnings from continuing operations

   $ 0.21     $ 0.20     $ 0.48     $ 0.31  

Loss from discontinued operations

     —         (0.11 )     —         (0.28 )
    


 


 


 


Net earnings

   $ 0.21     $ 0.09     $ 0.48     $ 0.03  
    


 


 


 


Earnings (loss) per share – diluted

                                

Earnings from continuing operations

   $ 0.20     $ 0.20     $ 0.47     $ 0.30  

Loss from discontinued operations

     —         (0.11 )     —         (0.27 )
    


 


 


 


Net earnings

   $ 0.20     $ 0.09     $ 0.47     $ 0.03  
    


 


 


 


Weighted average basic shares outstanding

     27,032       27,099       27,067       27,034  

Weighted average diluted shares outstanding

     27,781       27,926       27,733       27,801  
    


 


 


 


Cash dividends declared per common share

   $ 0.0625     $ 0.0600     $ 0.1825     $ 0.1750  
    


 


 


 


 

See accompanying notes to consolidated financial statements.

 

4


Table of Contents

CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

 

     Nine months ended

 

(In thousands)


   November 27,
2004


    November 29,
2003


 

Operating Activities

                

Net earnings

   $ 13,034     $ 906  

Adjustments to reconcile net earnings to net cash provided by operating activities:

                

Net (income) loss from discontinued operations

     (67 )     7,458  

Depreciation and amortization

     13,415       15,068  

Deferred income taxes

     (1,086 )     723  

Equity in loss of affiliated companies

     548       822  

Gain on disposal of assets

     (1,185 )     (760 )

Other, net

     383       (350 )

Changes in operating assets and liabilities, net of effect of acquisitions:

                

Receivables

     (25,245 )     (2,332 )

Inventories

     (726 )     931  

Accounts payable and accrued expenses

     3,999       (12,187 )

Billings in excess of costs and earnings on uncompleted contracts

     6,698       1,441  

Refundable and accrued income taxes

     13,537       (4,293 )

Other, net

     (86 )     (5 )
    


 


Net cash provided by continuing operating activities

     23,219       7,422  
    


 


Investing Activities

                

Capital expenditures

     (14,515 )     (7,850 )

Proceeds from sales of property, plant and equipment

     1,029       71  

Investments in equity investments

     (12 )     (57 )

Purchases of marketable securities

     (26,533 )     (11,261 )

Sales/maturities of marketable securities

     27,329